Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-04-07

FDA Approved: LEVETIRACETAM — Supplemental Application (SOHM, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for levetiracetam by SOHM, Inc., adding to the existing regulatory approval for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)